Skin structure
Ceftaroline in complicated skin and skin-structure infections
13
Presence of Genes Encoding the Panton Valentine Leukocidin Exotoxin Is Not the Primary Determinant of Outcome in Patients with Complicated Skin and Skin Structure Infections Due to Methicillin Resistant Staphylococcus aureus: Results of a Multinational Trial
6
Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review
9
The Prevalence of Methicillin Resistant Staphylococcus aureus Colonization in Patients with Complicated Skin and Skin Structure Infections after Treatment with Linezolid or Vancomycin
9
<p>Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy</p>
10
Early-stage bilayer tissue-engineered skin substitute formed by adult skin progenitor cells produces an improved skin structure in vivo
15
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
18
Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
10
A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
10
Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
8
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole
11
New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
8
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
10
Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline
12
New developments in the management of severe skin and deep skin structure infections – focus <br /> on tedizolid
6
Role of telavancin in treatment of skin and skin structure infections
7
Genotypic Characteristics of Staphylococcus aureus Isolates from a Multinational Trial of Complicated Skin and Skin Structure Infections
7
Systematic review and network meta analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
11
Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant <em>Staphylococcus aureus</em>
15
Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?
10